EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Diuresis Efficacy in Ambulatory Congested Heart Failure Patients

Aharon Ronnie Abbo, Amit Gruber, Ina Volis, Doron Aronson, Nicolas Girerd, Søren Lund Kristensen, Robert Zukermann, Natalia Alberkant, Elena Sitnitsky, Anton Kruger, Polina Khasis, Evgeny Bravo und 3 weitere

JACC: Heart Failure · 2024-08 · 12 (8) · 1396-1405

DOI: 10.1016/j.jchf.2024.04.014 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Heart Failure, 2024-08. Verfasst von Aharon Ronnie Abbo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Heart Failure Unit, Department of Cardiology and the Rambam Health Care Campus, Haifa, Israel. Hauptthemen laut MEDLINE: Heart Failure, Furosemide, Diuretics, Acetazolamide. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Limited evidence exists regarding efficacy and safety of diuretic regimens in ambulatory, congestion-refractory, chronic heart failure (CHF) patients. OBJECTIVES: The authors sought to compare the potency and safety of commonly used diuretic regimens in CHF patients. METHODS: A prospective, randomized, open-label, crossover study conducted in NYHA functional class II to IV CHF patients, treated in an ambulatory day-care unit. Each patient received 3 different diuretic regimens: intravenous (IV) furosemide 250 mg; IV furosemide 250 mg plus oral metolazone 5 mg; and IV furosemide 250 mg plus IV acetazolamide 500 mg. Treatments were administered once a week, in 1 of 6 randomized sequences. The primary endpoint was total sodium excretion, and the secondary was total urinary volume excreted, both measured for 6 hours post-treatment initiation. RESULTS: A total of 42 patients were recruited. Administration of furosemide plus metolazone resulted in the highest weight of sodium excreted, 4,691 mg (95% CI: 4,153-5,229 mg) compared with furosemide alone, 3,835 mg (95% CI: 3,279-4,392 mg; P = 0.015) and to furosemide plus acetazolamide 3,584 mg (95% CI: 3,020-4,148 mg; P = 0.001). Furosemide plus metolazone resulted in 1.84 L of urine (95% CI: 1.63-2.05 L), compared with 1.58 L (95% CI: 1.37-1.8); P = 0.039 collected following administration of furosemide plus acetazolamide and 1.71 L (95% CI: 1.49-1.93 L) following furosemide alone. The incidence of worsening renal function was significantly higher when adding metolazone (39%) to furosemide compared with furosemide alone (16%) and to furosemide plus acetazolamide (2.6%) (P < 0.001). CONCLUSIONS: In ambulatory CHF patients, furosemide plus metolazone resulted in a significantly higher natriuresis compared with IV furosemide alone or furosemide plus acetazolamide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureFurosemideDiureticsAcetazolamideMetolazoneCross-Over StudiesHumansMaleFemaleAgedProspective StudiesMiddle AgedDrug Therapy, CombinationDiuresisTreatment Outcome

Stichwörter der Autor:innen

acetazolamidecongestionday-carediureticsheart failure

Substanzen

FurosemideDiureticsAcetazolamideMetolazone

Autor:innen und Institutionen

  • Heart Failure Unit, Department of Cardiology and the Rambam Health Care Campus, Haifa, Israel.
  • Heart Failure Unit, Department of Cardiology and the Rambam Health Care Campus, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Université de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, CHRU Nancy, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
  • Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Heart Failure Unit, Department of Cardiology and the Rambam Health Care Campus, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; Clinical Research Institute at Rambam (CRIR), Haifa,…

Zitieren

APA

Abbo, A. R., Gruber, A., Volis, I., Aronson, D., Girerd, N., Lund Kristensen, S., Zukermann, R., Alberkant, N., Sitnitsky, E., Kruger, A., Khasis, P., Bravo, E., Elad, B., Helmer Levin, L., & Caspi, O. (2024). Diuresis Efficacy in Ambulatory Congested Heart Failure Patients. JACC: Heart Failure, 12(8), 1396-1405. https://doi.org/10.1016/j.jchf.2024.04.014

Vancouver

Abbo AR, Gruber A, Volis I, Aronson D, Girerd N, Lund Kristensen S, et al. Diuresis Efficacy in Ambulatory Congested Heart Failure Patients. JACC: Heart Failure. 2024;12(8):1396-1405. doi:10.1016/j.jchf.2024.04.014

BibTeX
@article{Abbo2024,
  author = {Abbo, Aharon Ronnie and Gruber, Amit and Volis, Ina and Aronson, Doron and Girerd, Nicolas and Lund Kristensen, Søren and Zukermann, Robert and Alberkant, Natalia and Sitnitsky, Elena and Kruger, Anton and Khasis, Polina and Bravo, Evgeny and Elad, Boaz and Helmer Levin, Ludmila and Caspi, Oren},
  title = {Diuresis Efficacy in Ambulatory Congested Heart Failure Patients},
  journal = {JACC: Heart Failure},
  year = {2024},
  volume = {12},
  number = {8},
  pages = {1396--1405},
  doi = {10.1016/j.jchf.2024.04.014}
}
Kostenlos starten →